Compatibility of a Mild, Moisturizing Hand Cleanser for Patients With Mild to Moderate Hand Dermatitis
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 46
- 试验地点
- 2
- 主要终点
- Investigator Global Assessment
研究概览
简要总结
The purpose of this study is to find out if the use of a hand cleanser that adds moisture to the skin will help improve skin rashes caused by frequent hand washing (hand dermatitis).
详细描述
The objective of this protocol is to evaluate compatibility and potential benefits of daily use of a marketed mild, moisturizing hand cleanser for subjects/patients who experience mild to moderate hand dermatitis induced by frequent cleansing.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Investigator)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Between 18 and 65 years of age
- •In general good health
- •Hands free of cuts and abrasions
- •Agree to adhere to the requirements listed in the informed consent
- •Willing and able to use a mild, moisturizing, non-antibacterial cleanser for all hand washing purposes for the duration of the test period
- •Willing to refrain from participating in any other clinical research trial for the duration of the study
排除标准
- •Documented allergies to study product components, soaps, latex, or fragrances
- •History of the following conditions which may affect the response of the skin or the interpretation of the results: insulin dependent diabetes, or peripheral vascular diseases
- •Participating in a concurrent clinical study involving treatment of your hands
- •Currently using a prescription medication for hand dermatitis
研究组 & 干预措施
Mild moisturizing Hand Cleanser
The test group will be provided with a mild moisturizing hand cleanser for all hand cleansing needs during the duration of the study.
干预措施: Mild, moisturizing hand cleanser (Other)
Current Hand Cleanser
The control group will continue to use their current cleanser for all hand washing.
结局指标
主要结局
Investigator Global Assessment
时间窗: Wk 4
Changes in global disease severity on a scale from 0-4 with 0 being clear and 4 being severe
次要结局
未报告次要终点